Cargando…
MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells
CD97 shows a strong relationship with metastasis and poor clinical outcome in various tumors, including ovarian cancer. The expression of CD97 in metastatic ovarian cancer cells was higher than that in primary ovarian cancer cells. Mature miRNAs are frequently de-regulated in cancer and incorporated...
Autores principales: | Park, Ga Bin, Kim, Daejin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355618/ https://www.ncbi.nlm.nih.gov/pubmed/30622051 http://dx.doi.org/10.1016/j.neo.2018.12.005 |
Ejemplares similares
-
MicroRNA-503 and the Extended MicroRNA-16 Family in Angiogenesis
por: Caporali, Andrea, et al.
Publicado: (2011) -
Inhibiting MicroRNA-503 and MicroRNA-181d with Losartan Ameliorates Diabetic Nephropathy in KKAy Mice
por: Zhu, XinWang, et al.
Publicado: (2016) -
microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition
por: PENG, YANG, et al.
Publicado: (2014) -
Gliotoxin Enhances Autophagic Cell Death via the DAPK1-TAp63 Signaling Pathway in Paclitaxel-Resistant Ovarian Cancer Cells
por: Park, Ga-Bin, et al.
Publicado: (2019) -
MicroRNA-503 Exacerbates Myocardial Ischemia/Reperfusion Injury via Inhibiting PI3K/Akt- and STAT3-Dependent Prosurvival Signaling Pathways
por: He, Yanjing, et al.
Publicado: (2022)